Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Email lessons ease eating disorder symptoms during long wait times

NCT ID NCT07319936

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a simple email program could help adults with eating disorders while they wait for specialized care. 78 people on a waitlist were randomly assigned to receive weekly educational emails for four weeks or no emails. The goal was to see if the materials could reduce eating-disorder thoughts and improve body satisfaction and motivation to change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

78 people

The number who actually took part.

Started

May 2023

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1\. Between 18-65 years and have a diagnosis of Anorexia Nervosa, Bulimia Nervosa or Other Specified Feeding or Eating Disorders (OSFED) as defined by DSM-5 criteria. Exclusion Criteria: * Current substance use disorder * Comorbid psychotic disorder * Major physical symptoms that could interfere with the intervention or or requiring urgent care (referred to priority 1 during phone evals) * Body mass index lower than 15 * Pregnancy * Insufficient access to the internet (by phone, tablet or computer) to complete the intervention * Not being able to access 2-3 modules for 4 consecutive weeks. Information on presence of current substance use disorder, comorbid psychotic disorder, major physical symptoms, body mass index and pregnancy are based on information from the clinical referal form and information from the initial screening for treatment eligibility in the eating-disorder program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Douglas Mental Health University Instititute

    Montreal, Quebec, H4H 1R3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.